版本:
中国

BRIEF-ContraVir Pharma says TXL has completed phase 1 clinical trial in healthy volunteers, showing favorable safety, tolerability, drug distribution profile

April 11 ContraVir Pharmaceuticals Inc

* ContraVir Pharma- TXL has completed phase 1 clinical trial in healthy volunteers, showing favorable safety, tolerability, drug distribution profile Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐